Diffusion tensor imaging, an MRI technique, showed that significant differences in the brains of high-risk children who go on to develop autism can be seen before symptoms appear.
Diffusion tensor imaging (DTI), a magnetic resonance imaging technique, showed that significant differences in the brains of high-risk children who go on to develop autism can be seen before symptoms appear.
This is according to a study from the Center of Autism Research at the Children’s Hospital of Philadelphia (CHOP).
“[The] findings, while requiring replication, are a very important first step towards identifying a biomarker for autism risk,” said Sara Paterson, PhD, director of the Infant Neuroimaging Lab at the Center, and a co-author of the study.
Ninety-two high-risk infants (siblings of children with autism) underwent DTI at 6 months and behavioral assessments at 24 months. Most also received other imaging exams at 12 months and/or 24 months. The researchers found that the factional anisotropy (FA) trajectories for 12 of 15 fiber tracts were significantly different between 28 infants at 6 months who at 24 months met the criteria for autism spectrum disorders (ASD) and the 64 who did not.
The infants diagnosed with an ASD had elevated FA at age 6 months, but slower development over time, which resulted in lower FA values at 24 months than had the other infants. The study was published in the American Journal of Psychiatry.
More studies are needed to confirm these findings but this discovery would allow for early intervention, which has been shown to improve outcomes among children with an ASD.
“This would enable specialists to diagnose autism much earlier than is currently possible through behavioral observations,” said Patterson.
Can MRI-Based AI Enhance Pre-Op Prediction of Tumor Deposits in Patients with Rectal Cancer?
October 31st 2024For patients with rectal cancer, an emerging nomogram that combines deep learning and clinical factors had greater than 16 percent and 23 percent increases in accuracy and specificity, respectively, for pre-op prediction of tumor deposits in comparison to clinical factors alone.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.